pyrimidine has been researched along with kynurenine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beconi, MG; Beresford, A; Brookfield, FA; Brown, CJ; Cardaun, I; Courtney, SM; Dijkman, U; Dominguez, C; Friley, WW; Hamelin-Flegg, E; Johnson, PD; Kempf, V; Lyons, K; Matthews, K; Mitchell, WL; Mrzljak, L; Munoz-Sanjuan, I; O'Connell, C; Pena, P; Powell, K; Prime, ME; Rassoulpour, A; Reed, L; Reindl, W; Selvaratnam, S; Toledo-Sherman, LM; Weddell, DA; Went, NE; Wheelan, P; Winkler, C; Winkler, D; Wityak, J; Yarnold, CJ; Yates, D | 1 |
1 other study(ies) available for pyrimidine and kynurenine
| Article | Year |
|---|---|
Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease.
Topics: Animals; Cell Proliferation; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Huntington Disease; Kynurenine; Kynurenine 3-Monooxygenase; Mice; Models, Molecular; Molecular Structure; Pyrimidines; Rats; Structure-Activity Relationship | 2015 |